1.
2.
Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance
by Kurki, P
Gut, 1980-10, Vol.21 (10), p.878-884
3.
Biliary lipid secretion in chronic cholestatic liver disease
by Kesäniemi, Y A
Gut, 1982-11, Vol.23 (11), p.931-938
4.
Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment
by Salaspuro, M P
Gut, 1981-11, Vol.22 (11), p.901-906
5.
6.
Endotoxin and liver diseases. High titres of enterobacterial common antigen antibodies in patients with alcoholic cirrhosis
by Turunen, U
Gut, 1981-10, Vol.22 (10), p.849-853
7.
Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C1 allele, possibly due to salivary acetaldehyde
by Visapää, J P
Gut, 2004-06, Vol.53 (6), p.871-876
8.
In vitro acetaldehyde formation by human colonic bacteria
by Jokelainen, K
Gut, 1994-09, Vol.35 (9), p.1271-1274
9.
Demonstration of an intracellular copper-binding protein by orcein staining in long-standing cholestatic liver diseases
by Salaspuro, M
Gut, 1976-10, Vol.17 (10), p.787-790
